Anti-Oxidative, Anti-Apoptotic, and M2 Polarized DSPC Liposome Nanoparticles for Selective Treatment of Atherosclerosis [Corrigendum]

Anti-Oxidative, Anti-Apoptotic, and M2 Polarized DSPC Liposome Nanoparticles for Selective Treatment of Atherosclerosis [Corrigendum]

Blog Article

Wan J, Yang J, Lei W, activecare spitfire et al.Int J Nanomedicine.2023;18:579-594.The authors have advised due to an error that occurred inadvertently at the time of figure assembly, Figure 5A on page 589 is incorrect.

The correct Figure 5 is as follows.Figure 5 Continued.Figure 5 The effect of liposome nanoparticles on M2 polarization.(A) Morphological changes of cells after incubating by all x515ea-bh55-cb groups.

Scale bar=20 μm.(B) Representative fluorescent pictures by CD206 staining of all groups in RAW.Scale bar=40 μm.(C) Fluorescence percentage of quantitative CD206 positive cells in RAW.

(D) Average fluorescence intensity of CD206 in RAW.**p < 0.05, ***p < 0.001.

Abbreviation: ns, no statistical significance.The authors apologise for this error.